<DOC>
	<DOCNO>NCT00154037</DOCNO>
	<brief_summary>The study design test hypothesis healthy subject candesartan pioglitazone provide additional vascular relax modulate effect addition blood-pressure blood glucose level reduce ability , respectively .</brief_summary>
	<brief_title>Investigation Vascular Relaxing Effects Candesartan Pioglitazone .</brief_title>
	<detailed_description>The aim study investigate effect oral candesartan and/ rosiglitazone therapy vascular responsiveness different vasoactive compound ( angiotensin II , insulin , histamine glyceroltrinitrate ) healthy subject . Pioglitazone give orally ( 4 week 30mg/d , titrate 45 mg/d another 4 week ) . Candesartan give orally ( 4 week 8mg/d , titrate 16 mg/d another 4 week ) treatment . Every subject receive intravenous stimulation phenylephrine , angiotensin II , histamine , insulin glyceroltrinitrate 8 week treatment interval study medication placebo . In addition , pulse wave velocity measure non-invasively treatment .</detailed_description>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Male healthy 18 40 year old nonsmoker additional medication relevant disease smoker elevate liver enzymes body weight different Broca Norm &gt; 20 % allergy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>vascular reactivity</keyword>
	<keyword>venodilation</keyword>
	<keyword>pulse wave velocity</keyword>
</DOC>